Skip to main content
. 2017 Dec 5;20(4):1029–1033. doi: 10.1111/dom.13147

Figure 1.

Figure 1

Forest plots for the comparative glycaemic durability of DPP‐4 inhibitors and SUs. A, Changes in HbA1c levels from 24 to 28 to 104 weeks of treatment; B, changes in HbA1c levels from 52 to 104 weeks of treatment. i.v., intravenous; s.d., standard deviation